Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Rationale Dextromethorphan (DXM) and its metabolite, dextrorphan (DXO) have neuroprotective and anticonvulsant properties through their activity as N-methyl-D-aspartate (NMDA) receptor channel blockers. Based on this receptor activity, coupled with reports of DXM abuse, both were evaluated for abuse potential and phencyclidine (PCP)-like behavioral effects in two animal models. Objectives and methods The discriminative stimulus properties of DXO and DXM were tested in rats (3-56 mg/kg DXM, i.p. and 2.2-40.9 mg/kg DXO, i.p.) and rhesus monkeys (0.3-10 mg/kg DXM, i.m. and 0.25-8.0 mg/kg DXO, i. m.) trained to discriminate PCP from saline using a standard two-lever drug-discrimination paradigm under a fixed-ratio (FR) schedule of food reinforcement. In a second set of experiments, i.v. self-administration of DXO (10-100 microg/kg/infusion) and DXM (10-1000 microg/kg/infusion) were tested under a FR schedule of reinforcement in monkeys trained to lever press for infusions of PCP during daily 1-h sessions. Results In rats, both DXM and DXO produced a dose-dependent substitution for PCP. When tested in monkeys, DXM yielded partial (1 monkey) and full (2 monkeys) substitution for PCP, while DXO substituted fully for PCP in all four subjects tested. In the self-administration study, in five of the six subjects, at least one dose of DXM served as a positive reinforcer, maintaining infusion rates above those for saline. For DXO, at least one dose maintained infusion numbers well above…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The behavioral pharmacology of NMDA receptor antagonists
Willetts, J., Balster, R. L., & Leander, J. D. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90150-7 · Cited by 330
Self-citationParsons, C. G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., & Danysz, W. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00092-k · Cited by 311
Parsons, C. G., Gruner, R., Rozental, J., Millar, J., & Lodge, D. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90029-3 · Cited by 279
Mao, J., Price, D. D., Hayes, R. L., Lu, J., Mayer, D. J., & Frenk, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)91368-3 · Cited by 238
Dextromethorphan An Overview of Safety Issues
Bem, J. L., & Peck, R. (1992) · Drug Safety · doi:10.2165/00002018-199207030-00004 · Cited by 223
Drug abuse potential evaluation in animals
BALSTER, R. L. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01747.x · Cited by 179
Self-citationBrady, K. T., Balster, R. L., & May, E. L. (1982) · Science · doi:10.1126/science.6274022 · Cited by 165
Self-citationPhencyclidine-like discriminative effects of opioids in the rat.
Holtzman, S. G. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32225-1 · Cited by 158
Church, J., Lodge, D., & Berry, S. C. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90755-1 · Cited by 155
Johanson, C. E., & Balster, R. L. (1978) · PubMed · Cited by 152
Self-citationNetzer, R., Pflimlin, P., & Trube, G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90849-d · Cited by 143
Dextromethorphan attenuates and reverses analgesic tolerance to morphine
Elliott, K., Hynansky, A., & Inturrisi, C. E. (1994) · Pain · doi:10.1016/0304-3959(94)90022-1 · Cited by 136
Porter, R. H. P., & Greenamyre, J. T. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020614.x · Cited by 136
Ilkjær, S., Dirks, J., Brennum, J., Wernberg, M., & Dahl, J. B. (1997) · British Journal of Anaesthesia · doi:10.1093/bja/79.5.600 · Cited by 135
Dextromethorphan inhibits NMDA-induced convulsions
Ferkany, J. W., Borosky, S. A., Clissold, D. B., & Pontecorvo, M. J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90707-8 · Cited by 125
Aram, J. A., Martin, D., Tomczyk, M., Zeman, S., Millar, J., Pohler, G., & Lodge, D. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23652-7 · Cited by 100
Klein, M., & Musacchio, J. M. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20705-4 · Cited by 99
N-Methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencylidine-like drugs
Leander, J. D., Lawson, R. R., Ornstein, P. L., & Zimmerman, D. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)91107-9 · Cited by 99
ACTIONS AND ADDICTION LIABILITIES OF DROMORAN DERIVATIVES IN MAN
Isbell, H., & Fraser, H. F. (1953) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)05201-2 · Cited by 93
Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture
Goldberg, M. P., Pham, P., & Choi, D. W. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90486-1 · Cited by 92
Massive dextromethorphan ingestion and abuse
Wolfe, T. R., & Caravati, E. M. (1995) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(95)90088-8 · Cited by 92
Beardsley, P. M., Hayes, B. A., & Balster, R. L. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20214-2 · Cited by 90
Self-citationNR1 and NR2 Subunit Contributions to N-Methyl-d-aspartate Receptor Channel Blocker Pharmacology
Monaghan, D. T., & Larsen, H. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36478-x · Cited by 87
Chapman, A. G., & Meldrum, B. S. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90060-5 · Cited by 85
Franklin, P. H., & Murray, T. F. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08814-5 · Cited by 83
Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey
Holtzman, S. G. (1982) · Psychopharmacology · doi:10.1007/bf00432758 · Cited by 80
Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects.
Aylward, M., Maddock, J., Davies, D. E., Protheroe, D. A., & Leideman, T. (1984) · PubMed · Cited by 79
Phencyclidine-like discriminative stimulus properties of MK-801 in rats
Willets, J., & Balster, R. L. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90498-0 · Cited by 79
Self-citationJackson, A., & Sanger, D. J. (1988) · Psychopharmacology · doi:10.1007/bf02431538 · Cited by 76
Young, A. M., & Woods, J. H. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32735-7 · Cited by 70
Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes
Murray, T. F., & Leid, M. E. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90121-8 · Cited by 69
Winger, G. D., Stitzer, M. L., & Woods, J. H. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30368-x · Cited by 64
Slifer, B. L., & Balster, R. L. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33622-0 · Cited by 62
Self-citationGenetic Polymorphism of Sparteine/Debrisoquine Oxidation: A Reappraisal
Lennard, M. S. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb00830.x · Cited by 61
Dizocilpine-like Discriminative Stimulus Effects of Low-affinity Uncompetitive NMDA Antagonists
Grant, K. A., Colombo, G., GRANT, J., & Rogawski, M. A. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00147-5 · Cited by 59
Wu, D., Otton, S. V., Kalow, W., & Sellers, E. M. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10693-9 · Cited by 59
Willetts, J. S. A., & Balster, R. L. (1988) · Neuropharmacology · doi:10.1016/0028-3908(88)90027-5 · Cited by 56
Self-citationBehavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists
Balster, R. L., Mansbach, R. S., Shelton, K. L., Nicholson, K. L., Grech, D. M., Wiley, J. L., Li, H., & Weber, E. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199508000-00018 · Cited by 55
Self-citationDependence on dextromethorphan hydrobromide.
Fleming, P. M. (1986) · BMJ · doi:10.1136/bmj.293.6547.597 · Cited by 54
Church, J., Shacklock, J. A., & Baimbridge, K. G. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90101-x · Cited by 52
Steinberg, G. K., Kunis, D. M., DeLaPaz, R. L., & Poljak, A. (1993) · Neurological Research · doi:10.1080/01616412.1993.11740131 · Cited by 50
Gollamudi, R., Williams, F. D., & Emele, J. F. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660740 · Cited by 50
France, C. P., Moerschbaecher, J. M., & Woods, J. H. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24770-x · Cited by 44
Church, J., Sawyer, D., & McLarnon, J. G. (1994) · Brain Research · doi:10.1016/0006-8993(94)90771-4 · Cited by 44
Benylin (dextromethorphan) abuse and mania.
Walker, J., & Yatham, L. N. (1993) · BMJ · doi:10.1136/bmj.306.6882.896 · Cited by 43
An Open Label Trial of Dextromethorphan in Huntingtonʼs Disease
Walker, F. O., & Hunt, V. P. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198908000-00010 · Cited by 42
Discriminative stimulus effects of dextromethorphan in the rat
Holtzman, S. G. (1994) · Psychopharmacology · doi:10.1007/bf02245325 · Cited by 40
Nankai, M., Klarica, M., Fage, D., & Carter, C. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00180-2 · Cited by 38
Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients.
Schmitt, B., Netzer, R., Fanconi, S., Baumann, P., & Boltshauser, E. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.3.333 · Cited by 36
Factors controlling drug reinforced behavior
Meisch, R. A. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90584-3 · Cited by 35
Nicholson, K. L., Jones, H. E., & Balster, R. L. (1998) · PubMed · Cited by 35
Self-citationBeardsley, P. M., & Balster, R. L. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90044-q · Cited by 30
Self-citationPhencyclidine: A Drug of Abuse and a Tool for Neuroscience Research
Balster, R. L., & Willetts, J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_6 · Cited by 27
Self-citationBalster, R. L., Nicholson, K. L., & Sanger, D. J. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90076-0 · Cited by 27
Self-citationAnalgesic effects of phencyclidine-like drugs in rhesus monkeys.
France, C. P., Snyder, A. M., & Woods, J. H. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21336-2 · Cited by 25
Discriminative stimulus and reinforcing properties of etoxadrol and dexoxadrol in monkeys.
Brady, K. T., Woolverton, W. L., & Balster, R. L. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32896-x · Cited by 25
Self-citationCytochrome P450IID subfamily in non-human primates
Jacqz-Aigrain, É., Guéguen, M., Zanger, U. M., Robieux, I., & Álvarez, F. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90166-3 · Cited by 17
Discriminative Stimulus Properties of Phencyclidine and Other NMDA Antagonists
Balster, R. L. (1991) · PsycEXTRA Dataset · doi:10.1037/e496182006-011 · Cited by 16
Self-citationIntroduction: The Control of Behavior by Consequent Drug Injections
Morse, W. H. (1975) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06684-0 · Cited by 11
Ketamine-like discriminative effects of some opioids in Rhesus monkeys
Herling, S., Solomon, R. E., & Woods, J. H. (1981) · The Pharmacologist · Cited by 3
Cited by
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312
“It is also surprising that none of the subjects classified dextromethorphan as a dissociative anesthetic, since dextromethorphan is abused for its dissociative-like effects (Boyer, 2004) and produces phencyclidine- and ketamine-like discriminative stimulus effects in rats (Nicholson et al., 1999; Narita et al., 2001).”
BackgroundA REVIEW OF KETAMINE ABUSE AND DIVERSION: Review: Ketamine
Sassano-Higgins, S., Baron, D., Juarez, G., Esmaili, N., & Gold, M. (2016) · Depression and Anxiety · doi:10.1002/da.22536 · Cited by 204
The predictive validity of the rat self-administration model for abuse liability
O’Connor, E. C., Chapman, K., Butler, P., & Mead, A. N. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.012 · Cited by 203
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block
Dravid, S. M., Erreger, K., Yuan, H., Nicholson, K., Le, P., Lyuboslavsky, P., Almonte, A., Murray, E., Mosley, C., Barber, J., et al. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.124958 · Cited by 184
Self-citationHigh doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens
Reissig, C. J., Carter, L. P., Johnson, M. W., Mintzer, M. Z., Klinedinst, M. A., & Griffiths, R. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2680-6 · Cited by 89
Metadata
- Authors
- Nicholson, K. L., Hayes, B. A., & Balster, R. L.
- Affiliations
- Virginia Commonwealth University (US)
- United States Food and Drug Administration (US)
- Venue
- Psychopharmacology
- Published
- 1999-09-03
- Volume
- 146
- Issue
- 1
- Pages
- 49-59
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2010580044
- Cited by
- 52
- References
- 60
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 1 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 07027, DA-01442, R01DA001442, T32DA007027)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- dextromethorphan, dextrorphan, abuse liability, discriminative stimulus, self-administration, NMDA receptor antagonism, drug substitution, drug abuse, rhesus monkeys, rats
- MeSH terms
- Animals, Antitussive Agents, Dextromethorphan, Discrimination Learning, Dose-Response Relationship, Drug, Macaca mulatta, Male, Phencyclidine, Reinforcement, Psychology, Self Administration, Receptors, N-Methyl-D-Aspartate, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.